Matthews Group

Chemical Biology

[Matthews Group @MegaMatthewsLab]

@KLabGPCR Thank you Kiril!!!!! I love RGSs!!!!

[Matthews Group @MegaMatthewsLab]

@ChristiansonLab Thank you!

[Matthews Group @MegaMatthewsLab]

1/14 Our latest study just out on BioRxiv [https://t.co/IVSLzPxHuj] has unusual personal significance for me. It connects two apparently unrelated diseases – (pre)eclampsia and glioblastoma – that have both impacted my family.

[Kirill Martemyanov Lab @KLabGPCR]

A popular FDA-approved drug to treat hypertension, hydralazine works, at least in part, by modulating RGS proteins! Honored to be a part of a collaborative team led by @MegaMatthewsLab!
https://t.co/aVVqDcsgy4

[Matthews Group @MegaMatthewsLab]

@PennChemistry, @PennMedicine, @biorxivpreprint, @BrainCancerCtr, @WHO, @CovalentMod

[Matthews Group @MegaMatthewsLab]

14/14 We are extremely excited to leverage these new findings for (pre)eclampsia and glioblastoma drug development, and we are actively seeking investors and partners for our company, Zenagem, LLC, to move forward.

[Matthews Group @MegaMatthewsLab]

I’m speaking at ‘Emergence of irreversible modulation in drug discovery’ on 16-17 October 2024! Join us in Cambridge where we will bring together established leaders and emerging investigators exploring irreversible covalent modulators. Register now: https://t.co/7B9WK5bYhP”

[Penn Chemistry @PennChemistry]

Our annual awards ceremony was a blast! Congrats to all of the recipients.